Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: A study in human brain tumors

Academic Radiology

Volumn 8, Issue 5, 2001, Pages 384-391

  Roberts, Heidi C ^a   Roberts, Timothy P L ^a   Bollen, Andrew W ^a   Ley, Sebastian ^b   Brasch, Robert C ^a   Dillon, William P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Brain neoplasms; MR; Staging

Indexed keywords

GADODIAMIDE; MONOCLONAL ANTIBODY KI 67;

BLOOD VESSEL PERMEABILITY; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION FUNCTION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MICROVASCULATURE; MITOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

EID: 0034922252     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)80545-7     Document Type: Conference Paper

References (50)

1. Location of focal silver staining at endothelial gaps in inflamed venules examined by scanning electron microscopy
2. Extravascular transport in normal and tumor tissues
3. Extravascular diffusion in normal and neoplastic tissues
4. Assessing tumor angiogenesis using macromolecular MR imaging contrast media
5. The role of angiogenesis in tumor growth
6. Vascular and interstitial barriers to delivery of therapeutic agents in tumors
7. Contrast-enhanced MR imaging assessment of tumor capillary permeability: Effect of irradiation on delivery of chemotherapy
8. Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density
9. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media
10. Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: Comparison of macromolecular and small-molecular contrast media - Preliminary experience
11. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor
12. Effects of anti-VEGF antibody on malignant gliomas assessed by dynamic contrast-enhanced MRI
13. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: Correlation with histological grade
14. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI
15. Physiologic measurements by contrast-enhanced MR imaging: Expectations and limitations
16. Quantification of liver blood volume: Comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI) with dynamic 3D gradient-recalled echo imaging
17. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging
18. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts
19. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive technique
20. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution
21. The flow of solute and solvent across a two-membrane system
22. Graphic evaluation of blood-to-brain transfer constants from multiple-time uptake data
23. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas
24. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters
25. Proliferation index as a predictor of prognosis in malignant gliomas of childhood
26. Proliferative activity and prognosis of low-grade astrocytomas
27. Echo-planar MR cerebral blood volume mapping of gliomas: Clinical utility
28. Tumor vascularity in the brain: Evaluation with dynamic susceptibility-contrast MR imaging
29. Susceptibility contrast imaging of cerebral blood volume: Human experience
30. In vivo measurements of regional cerebral blood flow and blood volume in patients with brain tumours using positron emission tomography
31. Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence
32. Diagnosis of recurrent brain tumor: Value of 201TI SPECT vs 18F-fluorodeoxyglucose PET
33. Thallium-201 brain tumor imaging: A comparative study with pathologic correlation
34. Thallium-201 SPECT imaging of brain tumors: Methods and results
35. Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme
36. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors
37. Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects
38. Contrast-enhanced perfusion-sensitive MR imaging in the diagnosis of cerebrovascular disorders
39. Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia
40. High-resolution measurement of cerebral brood flow using intravascular tracer bolus passages. II. Experimental comparison and preliminary results
41. High-resolution measurement of cerebral blood flow using intravascular tracer bolus passages. I. Mathematical approach and statistical analysis
42. Simultaneous MR acquisition of arterial and brain signal-time curves
43. Cerebral blood volume maps with dynamic contrast-enhanced T1-weighted FLASH imaging: Normal values and preliminary clinical results
44. Comparison of cerebral blood volume measurements using the T1 and T2* methods in normal human brains and brain tumors
45. False-positive cerebral blood volume maps: A potential pitfall in evaluation of monoclonal antibody-treated gliomas
46. Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability
47. Pharmacokinetic parameters in CNS Gd-DTPA-enhanced MR imaging
48. Regional comparison of tumor vascularity and permeability parameters measured by albumin Gd-DTPA and Gd-DTPA
49. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model